News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
496,015 Results
Type
Article (49813)
Company Profile (95)
Press Release (446107)
Multimedia
Podcasts (21)
Webinars (11)
Section
Business (136453)
Career Advice (1468)
Deals (23389)
Drug Delivery (60)
Drug Development (62001)
Employer Resources (108)
FDA (11205)
Job Trends (10544)
News (235128)
Policy (20452)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2684)
Academic (1)
Accelerated approval (4)
Adcomms (13)
Allergies (62)
Alliances (38506)
ALS (74)
Alzheimer's disease (1276)
Antibody-drug conjugate (ADC) (77)
Approvals (11228)
Artificial intelligence (201)
Autoimmune disease (17)
Automation (6)
Bankruptcy (203)
Best Places to Work (8479)
BIOSECURE Act (10)
Biosimilars (37)
Biotechnology (66)
Bladder cancer (53)
Brain cancer (24)
Breast cancer (202)
Cancer (1746)
Cardiovascular disease (122)
Career advice (1236)
Career pathing (20)
CAR-T (125)
Cell therapy (333)
Cervical cancer (14)
Clinical research (49527)
Collaboration (677)
Compensation (121)
Complete response letters (9)
COVID-19 (2109)
CRISPR (36)
C-suite (178)
Cystic fibrosis (76)
Data (1804)
Decentralized trials (2)
Denatured (8)
Depression (34)
Diabetes (186)
Diagnostics (4975)
Digital health (13)
Diversity (4)
Diversity, equity & inclusion (28)
Drug discovery (101)
Drug pricing (69)
Drug shortages (20)
Duchenne muscular dystrophy (62)
Earnings (50721)
Editorial (26)
Employer branding (15)
Employer resources (92)
Events (63138)
Executive appointments (566)
FDA (12126)
Featured Employer (24)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (564)
Gene editing (78)
Generative AI (18)
Gene therapy (220)
GLP-1 (474)
Government (2902)
Grass and pollen (4)
Guidances (46)
Healthcare (13349)
Huntington's disease (12)
IgA nephropathy (16)
Immunology and inflammation (62)
Indications (23)
Infectious disease (2221)
Inflammatory bowel disease (104)
Inflation Reduction Act (6)
Influenza (43)
Intellectual property (74)
Interviews (284)
IPO (11198)
IRA (34)
Job creations (2416)
Job search strategy (1065)
Kidney cancer (7)
Labor market (23)
Layoffs (263)
Leadership (10)
Legal (3826)
Liver cancer (55)
Lung cancer (243)
Lymphoma (115)
Machine learning (5)
Management (34)
Manufacturing (191)
MASH (50)
Medical device (8817)
Medtech (8820)
Mergers & acquisitions (12641)
Metabolic disorders (449)
Multiple sclerosis (62)
NASH (11)
Neurodegenerative disease (62)
Neuropsychiatric disorders (11)
Neuroscience (1681)
NextGen: Class of 2025 (4133)
Non-profit (3769)
Northern California (1819)
Now hiring (23)
Obesity (216)
Opinion (162)
Ovarian cancer (72)
Pain (57)
Pancreatic cancer (68)
Parkinson's disease (121)
Partnered (17)
Patents (173)
Patient recruitment (84)
Peanut (33)
People (40445)
Pharmaceutical (26)
Pharmacy benefit managers (8)
Phase I (15601)
Phase II (21580)
Phase III (16309)
Pipeline (964)
Policy (87)
Postmarket research (2072)
Preclinical (7584)
Press Release (65)
Prostate cancer (75)
Psychedelics (23)
Radiopharmaceuticals (186)
Rare diseases (262)
Real estate (4221)
Recruiting (39)
Regulatory (15194)
Reports (31)
Research institute (2538)
Resumes & cover letters (206)
Rett syndrome (3)
RNA editing (3)
RSV (29)
Schizophrenia (55)
Series A (91)
Series B (55)
Service/supplier (11)
Sickle cell disease (42)
Southern California (1601)
Special edition (13)
Spinal muscular atrophy (110)
Sponsored (27)
Startups (2465)
Stomach cancer (7)
Supply chain (43)
Tariffs (9)
The Weekly (12)
United States (16204)
Vaccines (510)
Venture capitalists (14)
Weight loss (127)
Women's health (16)
Worklife (11)
Date
Today (105)
Last 7 days (356)
Last 30 days (1967)
Last 365 days (25122)
2025 (6881)
2024 (26780)
2023 (30775)
2022 (41007)
2021 (43733)
2020 (41305)
2019 (32871)
2018 (24584)
2017 (24080)
2016 (23278)
2015 (27833)
2014 (20922)
2013 (18027)
2012 (18164)
2011 (19158)
2010 (17678)
Location
Africa (626)
Alabama (48)
Alaska (4)
Arizona (125)
Arkansas (7)
Asia (32194)
Australia (6953)
California (4172)
Canada (1533)
China (379)
Colorado (186)
Connecticut (219)
Delaware (89)
Europe (69874)
Florida (673)
Georgia (137)
Idaho (27)
Illinois (356)
India (26)
Indiana (215)
Iowa (5)
Japan (131)
Kansas (59)
Kentucky (14)
Louisiana (9)
Maine (48)
Maryland (630)
Massachusetts (3057)
Michigan (153)
Minnesota (213)
Mississippi (1)
Missouri (68)
Montana (23)
Nebraska (18)
Nevada (47)
New Hampshire (53)
New Jersey (1340)
New Mexico (28)
New York (1348)
North Carolina (729)
North Dakota (6)
Northern California (1819)
Ohio (145)
Oklahoma (8)
Oregon (19)
Pennsylvania (916)
Puerto Rico (7)
Rhode Island (16)
South America (793)
South Carolina (14)
Southern California (1601)
Tennessee (73)
Texas (643)
Utah (123)
Virginia (122)
Washington D.C. (51)
Washington State (450)
West Virginia (2)
Wisconsin (36)
496,015 Results for "research instruments limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Leica Biosystems Announces Partnership With Molecular Instruments As HCR™ Pro RNA-ISH Technology Is Released On The BOND RX and BOND RXm Research Staining Instruments
January 23, 2025
·
3 min read
Press Releases
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical’s Clinical Research at 2025 Annual Meeting
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session
March 10, 2025
·
5 min read
Opinion
AI Enables Companies to Break From the Herd in Drug Development
Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI could change that.
April 7, 2025
·
6 min read
·
Ruth Gross
Press Releases
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
·
3 min read
Press Releases
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation
April 15, 2025
·
7 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Press Releases
Patricia Industries’ subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
March 19, 2025
·
5 min read
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
Press Releases
Turbett Surgical Receives FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio
April 11, 2025
·
2 min read
Press Releases
Health Canada approves IMFINZI® (durvalumab) as the first and only immunotherapy regimen for adult patients with limited-stage small cell lung cancer (LS-SCLC)
April 10, 2025
·
6 min read
1 of 49,602
Next
